サマリー

市場分析とインサイト。世界のプソイドエフェドリン（Pseudoephedrine）市場
Pseudoephedrineの世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にXX百万米ドルに達すると予測しています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のPseudoephedrine市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には収益面での世界のPseudoephedrine市場全体のサイズも含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のPseudoephedrine市場で永続的な成功を収めるために利用できる効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のPseudoephedrine市場を詳細に調査するために、ユニークで業界最高の調査・分析手法を採用しました。

世界のプソイドエフェドリンの範囲と市場規模
プソイドエフェドリン市場は、企業別、地域（国）別、タイプ別、用途別に分類されています。世界のプソイドエフェドリン市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
医薬品有効成分
準備中

用途別セグメント
副鼻腔炎
うっ血性鼻炎
気管支喘息
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
ファイザー(ワイス)
エンド・インターナショナル
サノフィ
ハンミ
メルク
サイプレス・ファーマ
ジョンソン・エンド・ジョンソン
クローガー社
CVSケアマーク
Ratiopharm（Teva）社
UCB, Inc.
パシフィックファーマル
サン・ファーマル
アポテック
珠海天田製薬
Sichuan Shenghe Pharmaceutical

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pseudoephedrine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Active Pharmaceutical Ingredients
1.2.3 Preparation
1.3 Market by Application
1.3.1 Global Pseudoephedrine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Sinusitis
1.3.3 Congestive Rhinitis
1.3.4 Bronchial Asthma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pseudoephedrine Market Perspective (2016-2027)
2.2 Pseudoephedrine Growth Trends by Regions
2.2.1 Pseudoephedrine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pseudoephedrine Historic Market Share by Regions (2016-2021)
2.2.3 Pseudoephedrine Forecasted Market Size by Regions (2022-2027)
2.3 Pseudoephedrine Industry Dynamic
2.3.1 Pseudoephedrine Market Trends
2.3.2 Pseudoephedrine Market Drivers
2.3.3 Pseudoephedrine Market Challenges
2.3.4 Pseudoephedrine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pseudoephedrine Players by Revenue
3.1.1 Global Top Pseudoephedrine Players by Revenue (2016-2021)
3.1.2 Global Pseudoephedrine Revenue Market Share by Players (2016-2021)
3.2 Global Pseudoephedrine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pseudoephedrine Revenue
3.4 Global Pseudoephedrine Market Concentration Ratio
3.4.1 Global Pseudoephedrine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pseudoephedrine Revenue in 2020
3.5 Pseudoephedrine Key Players Head office and Area Served
3.6 Key Players Pseudoephedrine Product Solution and Service
3.7 Date of Enter into Pseudoephedrine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pseudoephedrine Breakdown Data by Type
4.1 Global Pseudoephedrine Historic Market Size by Type (2016-2021)
4.2 Global Pseudoephedrine Forecasted Market Size by Type (2022-2027)

5 Pseudoephedrine Breakdown Data by Application
5.1 Global Pseudoephedrine Historic Market Size by Application (2016-2021)
5.2 Global Pseudoephedrine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pseudoephedrine Market Size (2016-2027)
6.2 North America Pseudoephedrine Market Size by Type
6.2.1 North America Pseudoephedrine Market Size by Type (2016-2021)
6.2.2 North America Pseudoephedrine Market Size by Type (2022-2027)
6.2.3 North America Pseudoephedrine Market Size by Type (2016-2027)
6.3 North America Pseudoephedrine Market Size by Application
6.3.1 North America Pseudoephedrine Market Size by Application (2016-2021)
6.3.2 North America Pseudoephedrine Market Size by Application (2022-2027)
6.3.3 North America Pseudoephedrine Market Size by Application (2016-2027)
6.4 North America Pseudoephedrine Market Size by Country
6.4.1 North America Pseudoephedrine Market Size by Country (2016-2021)
6.4.2 North America Pseudoephedrine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pseudoephedrine Market Size (2016-2027)
7.2 Europe Pseudoephedrine Market Size by Type
7.2.1 Europe Pseudoephedrine Market Size by Type (2016-2021)
7.2.2 Europe Pseudoephedrine Market Size by Type (2022-2027)
7.2.3 Europe Pseudoephedrine Market Size by Type (2016-2027)
7.3 Europe Pseudoephedrine Market Size by Application
7.3.1 Europe Pseudoephedrine Market Size by Application (2016-2021)
7.3.2 Europe Pseudoephedrine Market Size by Application (2022-2027)
7.3.3 Europe Pseudoephedrine Market Size by Application (2016-2027)
7.4 Europe Pseudoephedrine Market Size by Country
7.4.1 Europe Pseudoephedrine Market Size by Country (2016-2021)
7.4.2 Europe Pseudoephedrine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pseudoephedrine Market Size (2016-2027)
8.2 Asia-Pacific Pseudoephedrine Market Size by Type
8.2.1 Asia-Pacific Pseudoephedrine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pseudoephedrine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pseudoephedrine Market Size by Type (2016-2027)
8.3 Asia-Pacific Pseudoephedrine Market Size by Application
8.3.1 Asia-Pacific Pseudoephedrine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pseudoephedrine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pseudoephedrine Market Size by Application (2016-2027)
8.4 Asia-Pacific Pseudoephedrine Market Size by Region
8.4.1 Asia-Pacific Pseudoephedrine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pseudoephedrine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pseudoephedrine Market Size (2016-2027)
9.2 Latin America Pseudoephedrine Market Size by Type
9.2.1 Latin America Pseudoephedrine Market Size by Type (2016-2021)
9.2.2 Latin America Pseudoephedrine Market Size by Type (2022-2027)
9.2.3 Latin America Pseudoephedrine Market Size by Type (2016-2027)
9.3 Latin America Pseudoephedrine Market Size by Application
9.3.1 Latin America Pseudoephedrine Market Size by Application (2016-2021)
9.3.2 Latin America Pseudoephedrine Market Size by Application (2022-2027)
9.3.3 Latin America Pseudoephedrine Market Size by Application (2016-2027)
9.4 Latin America Pseudoephedrine Market Size by Country
9.4.1 Latin America Pseudoephedrine Market Size by Country (2016-2021)
9.4.2 Latin America Pseudoephedrine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pseudoephedrine Market Size (2016-2027)
10.2 Middle East & Africa Pseudoephedrine Market Size by Type
10.2.1 Middle East & Africa Pseudoephedrine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pseudoephedrine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pseudoephedrine Market Size by Type (2016-2027)
10.3 Middle East & Africa Pseudoephedrine Market Size by Application
10.3.1 Middle East & Africa Pseudoephedrine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pseudoephedrine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pseudoephedrine Market Size by Application (2016-2027)
10.4 Middle East & Africa Pseudoephedrine Market Size by Country
10.4.1 Middle East & Africa Pseudoephedrine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pseudoephedrine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer (Wyeth)
11.1.1 Pfizer (Wyeth) Company Details
11.1.2 Pfizer (Wyeth) Business Overview
11.1.3 Pfizer (Wyeth) Pseudoephedrine Introduction
11.1.4 Pfizer (Wyeth) Revenue in Pseudoephedrine Business (2016-2021)
11.1.5 Pfizer (Wyeth) Recent Development
11.2 Endo International
11.2.1 Endo International Company Details
11.2.2 Endo International Business Overview
11.2.3 Endo International Pseudoephedrine Introduction
11.2.4 Endo International Revenue in Pseudoephedrine Business (2016-2021)
11.2.5 Endo International Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Pseudoephedrine Introduction
11.3.4 Sanofi Revenue in Pseudoephedrine Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Hanmi
11.4.1 Hanmi Company Details
11.4.2 Hanmi Business Overview
11.4.3 Hanmi Pseudoephedrine Introduction
11.4.4 Hanmi Revenue in Pseudoephedrine Business (2016-2021)
11.4.5 Hanmi Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Pseudoephedrine Introduction
11.5.4 Merck Revenue in Pseudoephedrine Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Cypress Pharma
11.6.1 Cypress Pharma Company Details
11.6.2 Cypress Pharma Business Overview
11.6.3 Cypress Pharma Pseudoephedrine Introduction
11.6.4 Cypress Pharma Revenue in Pseudoephedrine Business (2016-2021)
11.6.5 Cypress Pharma Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Pseudoephedrine Introduction
11.7.4 Johnson & Johnson Revenue in Pseudoephedrine Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Kroger Company
11.8.1 Kroger Company Company Details
11.8.2 Kroger Company Business Overview
11.8.3 Kroger Company Pseudoephedrine Introduction
11.8.4 Kroger Company Revenue in Pseudoephedrine Business (2016-2021)
11.8.5 Kroger Company Recent Development
11.9 CVS Caremark
11.9.1 CVS Caremark Company Details
11.9.2 CVS Caremark Business Overview
11.9.3 CVS Caremark Pseudoephedrine Introduction
11.9.4 CVS Caremark Revenue in Pseudoephedrine Business (2016-2021)
11.9.5 CVS Caremark Recent Development
11.10 Ratiopharm (Teva)
11.10.1 Ratiopharm (Teva) Company Details
11.10.2 Ratiopharm (Teva) Business Overview
11.10.3 Ratiopharm (Teva) Pseudoephedrine Introduction
11.10.4 Ratiopharm (Teva) Revenue in Pseudoephedrine Business (2016-2021)
11.10.5 Ratiopharm (Teva) Recent Development
11.11 UCB, Inc
11.11.1 UCB, Inc Company Details
11.11.2 UCB, Inc Business Overview
11.11.3 UCB, Inc Pseudoephedrine Introduction
11.11.4 UCB, Inc Revenue in Pseudoephedrine Business (2016-2021)
11.11.5 UCB, Inc Recent Development
11.12 Pacific Pharmal
11.12.1 Pacific Pharmal Company Details
11.12.2 Pacific Pharmal Business Overview
11.12.3 Pacific Pharmal Pseudoephedrine Introduction
11.12.4 Pacific Pharmal Revenue in Pseudoephedrine Business (2016-2021)
11.12.5 Pacific Pharmal Recent Development
11.13 Sun Pharmaceutical
11.13.1 Sun Pharmaceutical Company Details
11.13.2 Sun Pharmaceutical Business Overview
11.13.3 Sun Pharmaceutical Pseudoephedrine Introduction
11.13.4 Sun Pharmaceutical Revenue in Pseudoephedrine Business (2016-2021)
11.13.5 Sun Pharmaceutical Recent Development
11.14 Apotec
11.14.1 Apotec Company Details
11.14.2 Apotec Business Overview
11.14.3 Apotec Pseudoephedrine Introduction
11.14.4 Apotec Revenue in Pseudoephedrine Business (2016-2021)
11.14.5 Apotec Recent Development
11.15 Zhuhai Tianda Pharma
11.15.1 Zhuhai Tianda Pharma Company Details
11.15.2 Zhuhai Tianda Pharma Business Overview
11.15.3 Zhuhai Tianda Pharma Pseudoephedrine Introduction
11.15.4 Zhuhai Tianda Pharma Revenue in Pseudoephedrine Business (2016-2021)
11.15.5 Zhuhai Tianda Pharma Recent Development
11.16 Sichuan Shenghe Pharmaceutical
11.16.1 Sichuan Shenghe Pharmaceutical Company Details
11.16.2 Sichuan Shenghe Pharmaceutical Business Overview
11.16.3 Sichuan Shenghe Pharmaceutical Pseudoephedrine Introduction
11.16.4 Sichuan Shenghe Pharmaceutical Revenue in Pseudoephedrine Business (2016-2021)
11.16.5 Sichuan Shenghe Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details